                               SEQUENCE LISTING

<110> GEORGE MASON RESEARCH FOUNDATION, INC.
 
<120> METHODS OF LIPID NANOPARTICLE MANUFACTURE AND COMPOSITIONS DERIVED
      THEREFROM

<130> AEXR-002-02US-343269-2008

<140> 17/500,491
<141> 2021-10-13

<150> 63/179,885
<151> 2021-04-26

<150> 63/179,872
<151> 2021-04-26

<150> 63/091,616
<151> 2020-10-14

<150> 63/091,603
<151> 2020-10-14

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 250
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa       60

aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa      120

aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa      180

aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa      240

aaaaaaaaaa                                                             250


<210> 2
<211> 15
<212> PRT
<213> Clostridium tetani

<400> 2
Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15  


<210> 3
<211> 16
<212> PRT
<213> Clostridium tetani

<400> 3
Ala Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15      


<210> 4
<211> 101
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 4
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa       60

aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa a                          101


